Achondroplasia, Treatment

Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Ascendis Pharma, QED Therapeutics , Novartis, Sanofi, RIBOMIC

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom California

 
+91-9650213330
www.delveinsight.com 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/achondroplasia-treatment-drug-market-to-register-positive-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---ascendis-pharma-qed-therapeutics-bridgebio-novartis-sanofi-ribomic-302029275.html

en | boerse | 67941034 |